| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |